Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05443581
What this trial is testing

The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease

Who this might be right for
Metabolism and Nutrition DisorderLiver DiseasesObesity+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 220
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Not applicableStudy completedNCT07265011
What this trial is testing

Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD

Who this might be right for
MASLDPediatric
Jae Won Choi 50
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableStudy completedNCT04117802
What this trial is testing

Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome

Who this might be right for
OverweightMicrobiotaEndotoxemia+3 more
Laval University 47
Not applicableUnknownNCT05738707
What this trial is testing

Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Not applicableLooking for participantsNCT07652892
What this trial is testing

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.

Who this might be right for
Steatosis of Liver
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 140
Not applicableStudy completedNCT06289387
What this trial is testing

Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes

Who this might be right for
Type2diabetes
Medanta, The Medicity, India 1,000
Not applicableLooking for participantsNCT06386094
What this trial is testing

Cardiac Dysfunction in Patients with Fatty Liver Disease

Who this might be right for
NAFLDCardiac DiseaseFatty Liver+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 150
Not applicableLooking for participantsNCT05546086
What this trial is testing

BeijngFH Health Cohort Study

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital 8,103
Not applicableLooking for participantsNCT07188220
What this trial is testing

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07620366
What this trial is testing

To Evaluate the Efficacy and Safety of QL2401 in Patients With Metabolic Dysfunction-associated Steatohepatitis and Liver Fibrosis (F2-F3)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Qilu Pharmaceutical Co., Ltd. 132
Not applicableLooking for participantsNCT07541469
What this trial is testing

Rezdiffra Pregnancy and Lactation Registry

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc. 10
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableLooking for participantsNCT06335771
What this trial is testing

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

Who this might be right for
ObesityNonalcoholic Fatty LiverDiabetes Type 2+1 more
Bettina Mittendorfer 60
Not applicableNot Yet RecruitingNCT06135584
What this trial is testing

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseCirrhosis
The Affiliated Hospital of Hangzhou Normal University 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06798948
What this trial is testing

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

Who this might be right for
Metabolic-associated Fatty Liver Disease (MAFLD)
Li Lab,MD 100
Not applicableNot Yet RecruitingNCT06705868
What this trial is testing

Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.

Who this might be right for
MASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD+2 more
Cyprus University of Technology 150
Large-scale testing (Phase 3)WithdrawnNCT06692283
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Who this might be right for
MASLDMASHNASH+4 more
Sagimet Biosciences Inc.
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Next Page